MARKET

BBNX

BBNX

Beta Bionics, Inc.
NASDAQ
16.51
-1.30
-7.30%
After Hours: 16.46 -0.05 -0.30% 19:30 11/12 EST
OPEN
17.67
PREV CLOSE
17.81
HIGH
17.67
LOW
16.37
VOLUME
982.44K
TURNOVER
--
52 WEEK HIGH
32.71
52 WEEK LOW
8.80
MARKET CAP
897.60M
P/E (TTM)
-8.9451
1D
5D
1M
3M
1Y
5Y
1D
These healthcare stocks have tumbled in 2026, yet Quant ratings stay positive
Seeking Alpha · 2d ago
Weekly Report: what happened at BBNX last week (1102-1106)?
Weekly Report · 3d ago
BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit
Barchart · 11/03 16:20
BBNX Deadline Today: Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights
Barchart · 11/03 14:03
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
Barchart · 11/03 08:56
Weekly Report: what happened at BBNX last week (1026-1030)?
Weekly Report · 11/02 09:30
Beta Bionics Earnings Call: Mint Clearance Fuels Growth
TipRanks · 11/01 00:22
Beta Bionics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
Barchart · 10/30 18:10
More
About BBNX
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.

Webull offers Beta Bionics, Inc. stock information, including NASDAQ: BBNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBNX stock methods without spending real money on the virtual paper trading platform.